AngioDynamics Net Profit Margin 2010-2024 | ANGO
AngioDynamics net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| AngioDynamics Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-08-31 | $0.29B | $-0.24B | -83.22% |
| 2024-05-31 | $0.30B | $-0.18B | -60.53% |
| 2024-02-29 | $0.32B | $-0.19B | -59.26% |
| 2023-11-30 | $0.33B | $-0.01B | -3.94% |
| 2023-08-31 | $0.34B | $0.01B | 2.38% |
| 2023-05-31 | $0.34B | $-0.05B | -15.04% |
| 2023-02-28 | $0.34B | $-0.04B | -10.75% |
| 2022-11-30 | $0.33B | $-0.03B | -9.76% |
| 2022-08-31 | $0.32B | $-0.03B | -9.97% |
| 2022-05-31 | $0.32B | $-0.03B | -8.23% |
| 2022-02-28 | $0.31B | $-0.04B | -12.75% |
| 2021-11-30 | $0.30B | $-0.04B | -12.54% |
| 2021-08-31 | $0.30B | $-0.03B | -11.41% |
| 2021-05-31 | $0.29B | $-0.03B | -10.65% |
| 2021-02-28 | $0.27B | $-0.17B | -62.13% |
| 2020-11-30 | $0.27B | $-0.17B | -63.10% |
| 2020-08-31 | $0.27B | $-0.17B | -63.43% |
| 2020-05-31 | $0.26B | $-0.17B | -63.26% |
| 2020-02-29 | $0.28B | $0.05B | 17.69% |
| 2019-11-30 | $0.27B | $0.06B | 20.51% |
| 2019-08-31 | $0.27B | $0.06B | 22.34% |
| 2019-05-31 | $0.27B | $0.06B | 22.88% |
| 2019-02-28 | $0.21B | $0.01B | 2.43% |
| 2018-11-30 | $0.22B | $0.02B | 8.04% |
| 2018-08-31 | $0.24B | $0.02B | 6.64% |
| 2018-05-31 | $0.26B | $0.02B | 6.11% |
| 2018-02-28 | $0.26B | $0.00B | 0.38% |
| 2017-11-30 | $0.27B | $-0.01B | -3.77% |
| 2017-08-31 | $0.27B | $0.00B | 1.50% |
| 2017-05-31 | $0.27B | $0.01B | 1.85% |
| 2017-02-28 | $0.36B | $-0.03B | -7.02% |
| 2016-11-30 | $0.36B | $-0.03B | -7.56% |
| 2016-08-31 | $0.36B | $-0.04B | -11.48% |
| 2016-05-31 | $0.35B | $-0.04B | -12.18% |
| 2016-02-29 | $0.35B | $-0.00B | -0.29% |
| 2015-11-30 | $0.35B | $-0.01B | -1.71% |
| 2015-08-31 | $0.35B | $-0.01B | -1.42% |
| 2015-05-31 | $0.36B | $-0.00B | -1.12% |
| 2015-02-28 | $0.36B | $-0.01B | -1.39% |
| 2014-11-30 | $0.36B | $0.00B | 1.11% |
| 2014-08-31 | $0.36B | $0.00B | 0.84% |
| 2014-05-31 | $0.36B | $0.00B | 0.85% |
| 2014-02-28 | $0.35B | $0.00B | 1.14% |
| 2013-11-30 | $0.35B | $-0.00B | -0.58% |
| 2013-08-31 | $0.34B | 0 | 0.00% |
| 2013-05-31 | $0.34B | $-0.00B | -0.29% |
| 2013-02-28 | $0.31B | $-0.01B | -2.26% |
| 2012-11-30 | $0.28B | $-0.01B | -2.86% |
| 2012-08-31 | $0.25B | $-0.01B | -3.19% |
| 2012-05-31 | $0.22B | $-0.01B | -2.70% |
| 2012-02-29 | $0.22B | 0 | 0.00% |
| 2011-11-30 | $0.22B | $0.01B | 2.69% |
| 2011-08-31 | $0.22B | $0.01B | 3.21% |
| 2011-05-31 | $0.22B | $0.01B | 3.70% |
| 2011-02-28 | $0.22B | $0.01B | 5.91% |
| 2010-11-30 | $0.22B | $0.01B | 5.53% |
| 2010-08-31 | $0.22B | $0.01B | 5.53% |
| 2010-05-31 | $0.22B | $0.01B | 5.58% |
| 2010-02-28 | $0.21B | $0.01B | 5.29% |
| 2009-11-30 | $0.21B | $0.01B | 4.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.291B | $0.304B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.628B | 25.94 |
| Intuitive Surgical (ISRG) | United States | $186.738B | 97.63 |
| Alcon (ALC) | Switzerland | $45.674B | 32.15 |
| IQVIA Holdings (IQV) | United States | $39.509B | 21.77 |
| Edwards Lifesciences (EW) | United States | $38.832B | 24.66 |
| IDEXX Laboratories (IDXX) | United States | $35.456B | 41.76 |
| DexCom (DXCM) | United States | $26.916B | 40.53 |
| Waters (WAT) | United States | $22.926B | 33.90 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.977B | 0.00 |
| STERIS (STE) | Ireland | $21.252B | 24.49 |
| Hologic (HOLX) | United States | $18.417B | 19.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.517B | 12.85 |
| Sysmex ADR (SSMXY) | Japan | $12.405B | 38.90 |
| Globus Medical (GMED) | United States | $11.099B | 28.27 |
| Teleflex (TFX) | United States | $9.197B | 14.67 |
| Penumbra (PEN) | United States | $8.945B | 87.62 |
| Masimo (MASI) | United States | $8.639B | 41.80 |
| Glaukos (GKOS) | United States | $7.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.022B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.514B | 25.59 |
| Inari Medical (NARI) | United States | $3.035B | 0.00 |
| TransMedics (TMDX) | United States | $2.870B | 90.96 |
| Veracyte (VCYT) | United States | $2.868B | 86.84 |
| LivaNova (LIVN) | United Kingdom | $2.823B | 16.30 |
| Nihon Kohden (NHNKY) | Japan | $2.488B | 18.90 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 19.03 |
| Tandem Diabetes Care (TNDM) | United States | $2.188B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.968B | 10.29 |
| RxSight (RXST) | United States | $1.881B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.334B | 0.00 |
| Artivion (AORT) | United States | $1.214B | 80.50 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.011B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.939B | 15.96 |
| IRadimed (IRMD) | United States | $0.707B | 38.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.668B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.666B | 0.00 |
| SiBone (SIBN) | United States | $0.649B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 15.10 |
| Paragon 28 (FNA) | United States | $0.591B | 0.00 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.370B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.366B | 19.81 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.276B | 18.50 |
| Sight Sciences (SGHT) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.224B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.95 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.090B | 0.00 |
| LENSAR (LNSR) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |